Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
3.340
+0.020 (0.60%)
Feb 4, 2026, 10:25 AM CST

SHE:002390 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
962.051,016805.98899.18624.651,776
Cash & Short-Term Investments
962.051,016805.98899.18624.651,776
Cash Growth
27.88%26.00%-10.37%43.95%-64.84%43.76%
Accounts Receivable
2,5872,6913,0363,0913,0822,666
Other Receivables
321.23320.24324.63448.8600.56542.24
Receivables
2,9083,0123,3613,5403,6823,209
Inventory
928.241,0601,0011,033935.71843.39
Prepaid Expenses
-0.020.030.020.020
Other Current Assets
132.74164.39243.61334.34333.72262.83
Total Current Assets
4,9315,2525,4125,8065,5766,091
Property, Plant & Equipment
2,3392,4262,5182,6722,7062,323
Long-Term Investments
327.47337.47340.47343.84347.41223.03
Goodwill
603.75603.75603.75607.35607.35605.54
Other Intangible Assets
180.04189.54180.18204.37217.65219.56
Long-Term Deferred Tax Assets
81.581.8774.1462.8155.6146.51
Long-Term Deferred Charges
61.5669.381.8497.21118.36153.19
Other Long-Term Assets
67.3968.5735---
Total Assets
8,5929,0289,2459,7949,6299,662
Accounts Payable
713.79927.97903.15977.24993.43788.57
Accrued Expenses
13.7937.1535.2732.9940.9334.23
Short-Term Debt
306.96603.54809.861,3681,3903,410
Current Portion of Leases
3.934.42.51--
Current Income Taxes Payable
24.967.621.0917.2117.7916.46
Current Unearned Revenue
24.3325.9427.9833.2455.4439.62
Other Current Liabilities
291.74201.68256.82255.56256.6181.45
Total Current Liabilities
1,3791,8072,0592,6872,7554,470
Long-Term Debt
195.8160----
Long-Term Leases
17.972121.1222.0224.81-
Long-Term Unearned Revenue
23.8919.5222.0418.8920.3822.88
Long-Term Deferred Tax Liabilities
0.560.730.840.56--
Other Long-Term Liabilities
0.280.290.310.320.340.35
Total Liabilities
1,6182,0082,1032,7292,8004,494
Common Stock
1,9441,9441,9441,9442,0271,667
Additional Paid-In Capital
4,4034,4034,4034,4024,6933,624
Retained Earnings
601.97563.43633.34462.74354.9982.17
Treasury Stock
-199.93-199.93-127.49--455.38-455.38
Total Common Equity
6,7496,7106,8526,8086,6204,918
Minority Interest
224.9309.87289.69256.55208.74250.16
Shareholders' Equity
6,9747,0207,1427,0656,8295,169
Total Liabilities & Equity
8,5929,0289,2459,7949,6299,662
Total Debt
524.63787.55835.381,3931,4153,410
Net Cash (Debt)
437.42227.97-29.4-493.42-790.6-1,634
Net Cash Per Share
0.220.11-0.02-0.26-0.43-1.04
Filing Date Shares Outstanding
1,8961,8961,9071,9441,9441,584
Total Common Shares Outstanding
1,8961,8961,9071,9441,9441,584
Working Capital
3,5523,4453,3533,1192,8221,621
Book Value Per Share
3.563.543.593.503.413.11
Tangible Book Value
5,9655,9176,0685,9975,7954,093
Tangible Book Value Per Share
3.153.123.183.082.982.58
Buildings
-2,5172,5162,5782,3961,905
Machinery
-1,7161,7221,6971,6411,550
Construction In Progress
-145.0258.0624.9892.38122.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.